586 related articles for article (PubMed ID: 24365191)
1. Percutaneous renal sympathetic denervation: 2013 and beyond.
Froeschl M; Hadziomerovic A; Ruzicka M
Can J Cardiol; 2014 Jan; 30(1):64-74. PubMed ID: 24365191
[TBL] [Abstract][Full Text] [Related]
2. Renal denervation therapy for the treatment of resistant hypertension: a position statement by the Canadian Hypertension Education Program.
Khan NA; Herman RJ; Quinn RR; Rabkin SW; Ravani P; Tobe SW; Feldman RD; Wijeysundera HC; Padwal RS;
Can J Cardiol; 2014 Jan; 30(1):16-21. PubMed ID: 24269056
[TBL] [Abstract][Full Text] [Related]
3. Impact of renal denervation on 24-hour ambulatory blood pressure: results from SYMPLICITY HTN-3.
Bakris GL; Townsend RR; Liu M; Cohen SA; D'Agostino R; Flack JM; Kandzari DE; Katzen BT; Leon MB; Mauri L; Negoita M; O'Neill WW; Oparil S; Rocha-Singh K; Bhatt DL;
J Am Coll Cardiol; 2014 Sep; 64(11):1071-8. PubMed ID: 24858423
[TBL] [Abstract][Full Text] [Related]
4. Renal sympathetic denervation for resistant hypertension.
Froeschl M; Hadziomerovic A; Ruzicka M
Can J Cardiol; 2013 May; 29(5):636-8. PubMed ID: 23541665
[TBL] [Abstract][Full Text] [Related]
5. Catheter-based renal denervation for drug-resistant hypertension by using a standard electrophysiology catheter.
Prochnau D; Lucas N; Kuehnert H; Figulla HR; Surber R
EuroIntervention; 2012 Jan; 7(9):1077-80. PubMed ID: 21959556
[TBL] [Abstract][Full Text] [Related]
6. 12-month blood pressure results of catheter-based renal artery denervation for resistant hypertension: the SYMPLICITY HTN-3 trial.
Bakris GL; Townsend RR; Flack JM; Brar S; Cohen SA; D'Agostino R; Kandzari DE; Katzen BT; Leon MB; Mauri L; Negoita M; O'Neill WW; Oparil S; Rocha-Singh K; Bhatt DL;
J Am Coll Cardiol; 2015 Apr; 65(13):1314-1321. PubMed ID: 25835443
[TBL] [Abstract][Full Text] [Related]
7. [Renal artery denervation for treating refractory hypertension].
Benamer H; Louvard Y; Garot P; Unterseeh T; Hovasse T; Lefèvre T; Chevalier B; Morice MC
Ann Cardiol Angeiol (Paris); 2011 Dec; 60(6):354-60. PubMed ID: 22040858
[TBL] [Abstract][Full Text] [Related]
8. Endovascular renal artery denervation: why, when, and how?
Sapoval M; Azizi M; Bobrie G; Cholley B; Pagny JY; Plouin PF
Cardiovasc Intervent Radiol; 2012 Jun; 35(3):463-71. PubMed ID: 22314774
[TBL] [Abstract][Full Text] [Related]
9. Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial.
Bhatt DL; Vaduganathan M; Kandzari DE; Leon MB; Rocha-Singh K; Townsend RR; Katzen BT; Oparil S; Brar S; DeBruin V; Fahy M; Bakris GL;
Lancet; 2022 Oct; 400(10361):1405-1416. PubMed ID: 36130612
[TBL] [Abstract][Full Text] [Related]
10. Catheter-based renal sympathetic denervation: limitations to and gaps in the evidence.
Hiremath S; Froeschl M; Ruzicka M
Curr Opin Cardiol; 2014 Jul; 29(4):336-43. PubMed ID: 24859619
[TBL] [Abstract][Full Text] [Related]
11. Renal sympathetic denervation using an irrigated radiofrequency ablation catheter for the management of drug-resistant hypertension.
Ahmed H; Neuzil P; Skoda J; Petru J; Sediva L; Schejbalova M; Reddy VY
JACC Cardiovasc Interv; 2012 Jul; 5(7):758-65. PubMed ID: 22814781
[TBL] [Abstract][Full Text] [Related]
12. Catheter-based renal denervation for treatment of resistant hypertension.
Vase H; Mathiassen ON; Kaltoft A; Pedersen EB; Christensen KL; Buus NH; Lederballe O; Lassen JF; Bøtker HE; Thuesen L
Dan Med J; 2012 Jun; 59(6):A4439. PubMed ID: 22677237
[TBL] [Abstract][Full Text] [Related]
13. [Expert consensus statement on interventional renal sympathetic denervation for hypertension treatment].
Mahfoud F; Vonend O; Bruck H; Clasen W; Eckert S; Frye B; Haller H; Hausberg M; Hoppe UC; Hoyer J; Hahn K; Keller T; Krämer BK; Kreutz R; Potthoff SA; Reinecke H; Schmieder R; Schwenger V; Kintscher U; Böhm M; Rump LC;
Dtsch Med Wochenschr; 2011 Nov; 136(47):2418. PubMed ID: 22048949
[TBL] [Abstract][Full Text] [Related]
14. Results of the ALSTER BP real-world registry on renal denervation employing the Symplicity system.
Kaiser L; Beister T; Wiese A; von Wedel J; Meincke F; Kreidel F; Busjahn A; Kuck KH; Bergmann MW
EuroIntervention; 2014 May; 10(1):157-65. PubMed ID: 24472799
[TBL] [Abstract][Full Text] [Related]
15. [Renal denervation a treatment for resistant hypertension: a French experience].
Benamer H; Mylotte D; Garcia-Alonso C; Unterseeh T; Garot P; Louvard Y; Lefevre T; Morice MC;
Ann Cardiol Angeiol (Paris); 2013 Dec; 62(6):384-91. PubMed ID: 24182849
[TBL] [Abstract][Full Text] [Related]
16. Sympathetic renal denervation: hypertension beyond SYMPLICITY.
Barbash IM; Waksman R
Cardiovasc Revasc Med; 2013; 14(4):229-35. PubMed ID: 23928314
[TBL] [Abstract][Full Text] [Related]
17. Renal denervation in moderate treatment-resistant hypertension.
Ott C; Mahfoud F; Schmid A; Ditting T; Sobotka PA; Veelken R; Spies A; Ukena C; Laufs U; Uder M; Böhm M; Schmieder RE
J Am Coll Cardiol; 2013 Nov; 62(20):1880-6. PubMed ID: 23850901
[TBL] [Abstract][Full Text] [Related]
18. Blood Pressure Response to Main Renal Artery and Combined Main Renal Artery Plus Branch Renal Denervation in Patients With Resistant Hypertension.
Fengler K; Ewen S; Höllriegel R; Rommel KP; Kulenthiran S; Lauder L; Cremers B; Schuler G; Linke A; Böhm M; Mahfoud F; Lurz P
J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862930
[TBL] [Abstract][Full Text] [Related]
19. Effects of renal sympathetic denervation on cardiac sympathetic activity and function in patients with therapy resistant hypertension.
van Brussel PM; Eeftinck Schattenkerk DW; Dobrowolski LC; de Winter RJ; Reekers JA; Verberne HJ; Vogt L; van den Born BJ
Int J Cardiol; 2016 Jan; 202():609-14. PubMed ID: 26447672
[TBL] [Abstract][Full Text] [Related]
20. [Interventional renal sympathetic denervation - a new approach for patients with resistant hypertension].
Mahfoud F; Böhm M
Dtsch Med Wochenschr; 2010 Dec; 135(48):2422-5. PubMed ID: 21108158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
